Prognosis of CDKN2A germline mutation in patients with familial melanoma: a systematic review and meta-analysis. Taibo A, Paradela S, Suanzes-Hernandez J, Balboa-Barreiro V, et al. Melanoma Res 2023 Nov 2. doi: 10.1097/CMR.0000000000000920.

Read + Share

Amedeo Smart

Independent Medical Education

Taibo A, Paradela S, Suanzes-Hernandez J, Balboa-Barreiro V, et al. Prognosis of CDKN2A germline mutation in patients with familial melanoma: a systematic review and meta-analysis. Melanoma Res 2023 Nov 2. doi: 10.1097/CMR.0000000000000920.
PMID: 37924530